undamentalytics Newsletter

Reeve Graham D.: insider trades

Officer at U S Physical Therapy Inc. No open-market purchases and 26 sales not made under a pre-set plan, reported from August 13, 2019 to March 12, 2026.

What happened after Reeve Graham D.’s sales?

After their sales, the shares moved −21.0% against the index over 12 months on average (a negative figure means selling was the right call); 83% trailed it.

With 296 insiders tested, some will look skilled or unskilled by chance alone: when we replaced each insider’s stocks with random companies bought on the same days, about 5.7 cleared the bar ahead and 23.3 behind. One record on its own proves little.

Trade by trade

Reeve Graham D.: trades against the S&P 500 afterwards
MeasuredTrades countedAverage vs S&P 500MedianWent the right wayYearst-statisticp-valueEvidence
Purchases, 3 months after the report 0 — — — — — — Not enough years
Purchases, 6 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the trade 0 — — — — — — Not enough years
Sales, 3 months after the report 26 −4.1% −3.2% 54% 8 −1.14 0.29 No reliable evidence
Sales, 12 months after the report 23 −21.0% −23.7% 83% 7 −3.96 0.007 Strong evidence: seller right
Sales, 12 months after the trade 23 −20.4% −24.3% 83% 7 −3.74 0.010 Strong evidence: seller right

“Average vs S&P 500” is the stock’s return including dividends minus the index’s over the same dates, from the close on the first trading day after the report, or from the close on the trade date. Only windows that have finished are counted. For sales, a negative figure means the stock lagged after it was sold, so selling was the right call (green). “Went the right way” is the share of purchases that beat the index, or of sales that trailed it. The t-statistic uses one average per year of reports, because one person’s trades bunch into the same stock and weeks, and needs trades in at least four different years; the p-value comes from the t distribution with that number of years (with four years, a t of 2 has p = 0.14). “Some evidence” means p under 5%, “strong evidence” p under 1% over at least six years.

Companies traded

CompanyTitle on the latest filingPurchasesSalesFirst reportLatest report
U S Physical Therapy Inc USPH COO026August 13, 2019March 12, 2026

Trades and what followed

Moves are against the S&P 500; green means the trade went the insider’s way.

ReportedTradedCompanyTradeValue3 months after report12 months after report12 months after trade
March 12, 2026March 11, 2026 USPH Sale $52,205 −26.3%not yetnot yet
March 11, 2026March 6, 2026 USPH Sale $148,704 −25.5%not yetnot yet
November 25, 2025November 24, 2025 USPH Sale $52,760 +11.0%not yetnot yet
August 21, 2025August 21, 2025 USPH Sale $64,832 −22.7%−29.3%−27.0%
August 12, 2025August 11, 2025 USPH Sale $155,133 −21.7%−27.6%−25.9%
May 22, 2025May 21, 2025 USPH Sale $41,382 +5.0%−42.0%−46.7%
March 7, 2025March 7, 2025 USPH Sale $142,050 −7.9%−19.8%−17.7%
November 12, 2024November 8, 2024 USPH Sale $166,004 −6.0%−34.4%−37.6%
August 21, 2024August 21, 2024 USPH Sale $142,230 +8.7%−12.8%−10.3%
May 14, 2024May 10, 2024 USPH Sale $181,813 −27.5%−38.4%−40.2%
March 5, 2024March 4, 2024 USPH Sale $274,441 −10.1%−33.8%−33.2%
November 16, 2023November 15, 2023 USPH Sale $131,085 +9.1%−23.7%−26.6%
August 14, 2023August 11, 2023 USPH Sale $452,499 −21.0%−46.1%−39.8%
March 6, 2023March 2, 2023 USPH Sale $193,016 +6.0%−19.7%−24.3%
November 8, 2022November 7, 2022 USPH Sale $161,864 +8.3%−19.6%−20.7%
August 10, 2022August 8, 2022 USPH Sale $352,172 +3.7%+12.2%+10.5%
March 2, 2022February 28, 2022 USPH Sale $192,208 +24.1%+9.6%+20.9%
December 7, 2021December 6, 2021 USPH Sale $94,190 +8.6%+5.8%+7.9%
August 10, 2021August 9, 2021 USPH Sale $177,960 −13.3%−14.5%−14.8%
May 10, 2021May 7, 2021 USPH Sale $214,624 −11.9%−9.3%−11.8%
March 2, 2021March 1, 2021 USPH Sale $139,800 −1.6%−31.1%−33.5%
November 13, 2020November 10, 2020 USPH Sale $104,230 +14.5%−40.3%−35.3%
August 14, 2020August 12, 2020 USPH Sale $135,315 +12.7%−10.6%−8.7%
June 1, 2020May 28, 2020 USPH Sale $78,350 +3.7%+21.0%+17.1%
November 25, 2019November 22, 2019 USPH Sale $55,245 −4.8%−24.4%−22.9%
August 13, 2019August 12, 2019 USPH Sale $127,568 −22.6%−53.7%−48.8%

Open-market purchases and sales of at least $10,000 in companies we cover, from SEC Form 4 filings; sales made under a pre-set Rule 10b5-1 plan are not shown. “Not yet” means the window has not finished or the share price was under $5 at entry. These are the shares’ moves after each trade: they say nothing about why Reeve Graham D. traded and do not suggest the use of non-public information. How every insider compares · the insider trading backtest.